Thomas Bone-Winkel
Co-Founder / CFO

Biosavety provides a continuous indoor air quality solution using HOCl(g) technology to eliminate airborne pathogens, odors, and other contaminants in real-time. This system enhances hygiene and safety in dynamic environments while minimizing reliance on harmful chemicals, significantly reducing CO₂ emissions and maintenance costs.
Raised to date
$3.8MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Co-Founder / CFO
Many indoor environments struggle with persistent airborne pathogens, odors, and other contaminants, leading to hygiene and safety concerns. Traditional methods often rely on harsh chemicals, which can be unsustainable and pose health risks.
Biosavety offers a continuous indoor air quality solution leveraging HOCl(g) technology to eliminate airborne pathogens, odors, and other contaminants in real-time. The system uses a specialized electrolysis process to produce pure HOCl from salt and water, which is then dispersed as a gas to neutralize pollutants. Biosavety's system adapts dynamically to the environment, ensuring consistent hygiene without the need for manual intervention or harsh chemicals. Real-time monitoring and IoT connectivity provide users with complete control and visibility over their indoor air quality.
Biosavety serves a range of industries, including healthcare facilities, industrial plants, crop and livestock operations, and food production facilities, seeking to improve indoor air quality and hygiene.